Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

SOmatic MUtagenesis in Kidney Tubule is enhanced by specific metabolic pathways

Project description

The role of metabolism in somatic mutagenesis and cancer initiation

The accumulation of genetic mutations in specific driver genes in somatic cells may lead to malignant transformation. The aim of the EU-funded SoMuKT project is to understand the causes underlying this phenomenon and the rate at which mutations accumulate. Using a model for the detection of somatic mutations in normal cells, researchers have observed that proximal tubule cells in the kidney nephron show a unique mutation pattern. Based on these findings, they plan to perturb the metabolic homeostasis of the kidney to investigate if endogenously produced genotoxic compounds such as ammonia are responsible for somatic mutagenesis. Results will provide fundamental knowledge on the role of metabolism in genomic damage and cancer, with important clinical implications.

Objective

An important factor favoring cancer initiation is the lifelong accumulation of somatic mutations in the genome. In agreement, somatic mutations in a specific set of driver genes has been shown to drive the transition from a healthy cell to a tumorigenic clone in the kidney. The vast majority of kidney tumors originate from a specific segment of the kidney nephron, named proximal tubule (PT). However, the rate of somatic mutation accumulation before tumorigenic transformation in the kidney PT and the causes underlying this phenomenon are unexplored.
Somatic mutation data can be used as a footprint to track the mutational processes that occurred in a specific cell during an individual´s lifetime. I established a protocol for reliable detection of somatic mutations in non-cancer human cells. I obtained whole genome data from clonally expanded single cells from skeletal muscle, kidney, fat and skin of healthy donors. My preliminary data point to an increased rate of somatic mutation accumulation during adult life in kidney PT compared to other kidney and non-kidney cells. PT cells showed a unique mutation pattern and distribution that enhances the chances of acquiring a driver mutation and tumorigenic traits.
The very homogeneous pattern of somatic mutations in PT cells leads me to the hypothesis that the kidney PT is exposed to genotoxic compounds that are endogenously produced during physiological cellular activities. In particular, my data point to specific metabolic pathways, including 1) ammonia production, 2) aminoacid metabolism /reabsorption from the urine and 3) response to hypoxia. I will use cellular models to perturb the metabolic homeostasis of the kidney PT and test the effect on somatic mutagenesis and underlining mechanisms. My project will shed light on a mostly unexplored topic: how cellular metabolism can damage the genome over time and may have important implications for tumor prevention.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

MSCA-IF - Marie Skłodowska-Curie Individual Fellowships (IF)

See all projects funded under this funding scheme

Call for proposal

(opens in new window) H2020-MSCA-IF-2019

See all projects funded under this call

Coordinator

OSPEDALE SAN RAFFAELE SRL
Net EU contribution
€ 183 473,28
Address
VIA OLGETTINA 60
20132 Milano
Italy
Region
Nord-Ovest Lombardia Milano
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
€ 183 473,28